Skip to content

Clinical trials

Neoplasms by Site trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Belgium Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20142
20152
20162
20172
20182
20191
20201
20213
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting7
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
AstraZeneca2
Daiichi Sankyo2
Eli Lilly and Company2
Sumitomo Pharma America, Inc.2
Abbott1
BBB-Therapeutics B.V.1
Celgene1
Cogent Biosciences, Inc.1
Corcept Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site23
Neoplasms21
Digestive System Neoplasms8
Breast Neoplasms7
Digestive System Diseases7
Adenocarcinoma6
Breast Diseases6
Carcinoma6
Lung Neoplasms6
Neoplasms by Histologic Type6

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.